Access Campaign

MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine
MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumonia vaccine
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
MSF urges PM Modi not to make any trade commitments to US threatening access to medicines
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India